Facebook
Twitter
Telegram
Fehler meldenProtara Therapeutics Kennzahlen 2011-2024 | TARA
Kennzahlen Jährlich Protara Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.0 | -0.6 | -1.6 | -3.8 | -1.1 | -2.3 | -1.4 | -1.1 | -7.2 | -9.6 | - | - | - |
P/S |
- | - | - | - | - | - | - | - | - | 10.9 | - | - | - |
EPS |
-3.6 | -5.9 | -4.2 | -4.7 | -3.0 | -45.8 | -2.1 | -1.7 | -1.3 | -3.2 | -59.7 | -61.2 | - |
EV (Enterprise Value) |
12.4 M | 27.7 M | 50.8 M | -34.6 M | 11.2 M | 30.5 M | 30.4 M | 154 K | 118 M | -34.3 M | -2.79 M | -2.41 M | - |
EBITDA per Share |
-3.82 | -5.93 | -4.22 | -4.73 | -30.1 | -47 | -70 | -69 | -50.6 | -98.6 | - | - | - |
EV/EBITDA |
-0.9 | 1.1 | -0.7 | -1.3 | -0.7 | 0.2 | -5.5 | 4.9 | - | - | - | ||
PEG |
0.04 | 0.02 | 0.05 | -0.05 | -0.03 | -0.07 | 2.0 | 0.03 | 0.38 | 0.05 | - | - | - |
P/B |
0.6 | 0.4 | 0.5 | 0.7 | 2.6 | 2.3 | 1.2 | 0.8 | 2.4 | 0.4 | - | - | - |
P/CF |
-1.1 | -1.5 | -2.2 | -5.4 | -1.1 | -2.0 | -1.9 | -1.3 | -8.6 | -3.2 | - | - | - |
ROE % |
-59.16 | -64.61 | -29.18 | -17.05 | -234.54 | -101.40 | -86.25 | -74.21 | -33.72 | -4.05 | - | - | - |
ROA % |
-51.19 | -58.22 | -27.38 | -16.72 | -214.94 | -88.13 | -68.13 | -65.55 | -31.65 | -3.94 | - | - | - |
ROCE % |
-63.84 | -65.69 | -29.33 | -17.20 | -238.64 | -104.54 | -87.40 | -74.67 | -32.92 | -9.19 | - | - | - |
Current Ratio |
7.4 | 10.1 | 16.2 | 58.1 | 12.0 | 7.5 | 4.7 | 8.4 | 16.1 | 36.2 | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebszyklus |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Finanzkreislauf |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Kennzahlen Vierteljährlich Protara Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.97 | - | -0.87 | -1 | -0.8 | - | -0.68 | -0.76 | -0.96 | - | -0.96 | -1.14 | -1.2 | - | -1.26 | -1.22 | -1.81 | - | -0.92 | -0.56 | -0.58 | -0.27 | -0.25 | -0.28 | -0.34 | -0.33 | -1.08 | -0.33 | -0.39 | -0.42 | -0.43 | -0.48 | -0.4 | -0.38 | -0.33 | -0.31 | -0.28 | 0.52 | -31 | -18.55 | -18.09 | -16.41 | -15.6 | -13.33 | -14.64 | - | - | - | - | - | - | - | - |
EBITDA per Share |
-1.03 | - | - | - | -0.85 | - | -0.69 | -0.76 | -0.96 | - | -0.96 | -1.13 | -1.21 | - | -1.26 | -1.24 | -1.82 | - | -0.88 | -0.55 | -0.52 | - | -0.26 | -0.28 | -0.36 | - | -0.69 | -0.34 | -0.39 | - | -0.43 | -0.47 | -0.41 | - | -0.31 | -0.3 | -0.28 | - | 0.64 | -10.4 | -8.02 | - | -7.9 | - | - | - | - | - | - | - | - | - | - |
ROE % |
-57.87 | -35.61 | -41.13 | -33.85 | -26.47 | -18.46 | -24.79 | -25.58 | -26.88 | -20.65 | -24.65 | -22.32 | -18.74 | -12.63 | 97.99 | 212.62 | 283.34 | 249.57 | 227.51 | 94.82 | 3.82 | -75.67 | -111.10 | -124.47 | -116.74 | -70.28 | -88.39 | -71.45 | -75.87 | -74.21 | -66.10 | -56.10 | -43.54 | -33.72 | -14.94 | -12.73 | -7.84 | -4.05 | -10.44 | -2.06 | 1.04 | 4.48 | 2.09 | - | - | - | - | - | - | - | - | - | - |
ROA % |
-50.45 | -31.52 | -36.69 | -30.72 | -24.37 | -17.36 | -23.32 | -24.11 | -25.36 | -19.73 | -23.65 | -21.61 | -18.36 | -12.39 | -204.95 | -393.60 | -506.95 | -434.43 | -453.60 | -280.21 | -184.09 | -65.77 | -93.75 | -102.56 | -94.57 | -55.51 | -71.51 | -59.85 | -65.27 | -65.55 | -58.94 | -50.58 | -39.93 | -31.65 | -13.73 | -11.87 | -7.38 | -3.94 | -54.83 | -85.88 | -82.86 | -79.52 | -37.16 | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-62.34 | -38.42 | -44.15 | -35.97 | -27.71 | -18.86 | -25.21 | -25.84 | -27.02 | -20.74 | -24.79 | -22.48 | -18.96 | -12.79 | 97.83 | 212.51 | 283.29 | 249.57 | 226.96 | 93.73 | 2.13 | -78.20 | -113.63 | -126.44 | -119.22 | -71.31 | -89.95 | -73.17 | -76.37 | -56.81 | -64.83 | -54.20 | -41.63 | -23.16 | -22.99 | -14.82 | -10.00 | -5.22 | -3.32 | -1.58 | 1.46 | 1.90 | 1.90 | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
7.0 | 7.4 | 7.7 | 9.6 | 9.1 | 10.1 | 15.8 | 16.4 | 17.9 | 16.2 | 17.6 | 18.0 | 44.9 | 51.9 | 51.9 | 51.9 | 51.9 | 0.4 | 0.4 | 0.4 | 0.4 | 7.6 | 7.6 | 7.6 | 7.6 | 4.8 | 4.8 | 4.8 | 4.8 | 8.6 | 8.6 | 8.6 | 8.6 | 16.3 | 16.3 | 16.3 | 16.3 | 36.3 | 36.3 | 36.3 | 36.3 | 0.6 | 0.6 | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebszyklus |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Finanzkreislauf |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung